Literature DB >> 25755910

Imported visceral leishmaniasis - unexpected bone marrow diagnosis in a patient with fever, pancytopenia, and splenomegaly.

Valentina Gallina1, Raffaella Binazzi2, Arber Golemi3, Mohsen Farsad3, Günter Weiss4, Christian J Wiedermann1.   

Abstract

Leishmaniasis is spreading from mediterranean countries to the north of Europe. The Alps are not an endemic region and there are only few reports of sporadic cases. We report the case of a 72 year old male who presented after a syncope with fever, cough and a sacral skin rash. Clinical examination revealed splenomegaly, elevated liver enzymes and pancytopenia; differential diagnosis included myeloproliferative or lymphoproliferative disorders, infections and auto-immune conditions that cause enlargement of the spleen and liver diseases, however, all tests were negative. In (18)FDG PET computerized tomography, pathological and diffuse uptake in the spleen was seen, with mild and homogeneous FDG uptake in the bone marrow and normal tracer uptake elsewhere in the body. Bone marrow aspiration revealed the presence of numerous intra- and extracellular Leishmania amastigotes. Travel history indicated that he had been in Sardinia for a 7-day vacation several months ago. The patient promptly responded to treatment with liposomal amphotericin B. Imported visceral leishmaniasis is likely to be seen more frequently in non-endemic regions and fever, pancytopenia and splenomegaly are diagnostic clues, whereas diagnostic confirmation may be done by detection of Leishmania spp. amastigotes in the bone marrow.

Entities:  

Keywords:  Immunocompetent; hypersplenism; imaging; imported; visceral leishmaniasis

Year:  2014        PMID: 25755910      PMCID: PMC4348797     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN: 2160-1992


  11 in total

1.  Diffuse metabolic activation of reticuloendothelium on F-18 FDG PET imaging in a case of visceral leishmania.

Authors:  Andrea Lupi; Giuseppe Todeschini; Pierluigi Zanco
Journal:  Clin Nucl Med       Date:  2006-01       Impact factor: 7.794

2.  Focal splenic FDG uptake in a patient with Kala-Azar (visceral leishmaniasis).

Authors:  Jordi Fuertes; Josep-Roland Garcia-Bennett; Simona Iftimie; Mònica Danús; José Angel Abreu
Journal:  Clin Nucl Med       Date:  2014-04       Impact factor: 7.794

3.  18F-FDG uptake in multiple splenic foci on PET/CT: an unusual case of visceral leishmaniasis.

Authors:  Glenna M Gibson; Colin Arnold; Aravind S Ravi Kumar
Journal:  Clin Nucl Med       Date:  2014-09       Impact factor: 7.794

4.  Bone marrow parasite burden among patients with New World kala-azar is associated with disease severity.

Authors:  Joyce M Silva; Danielle A Zacarias; Lívio C de Figueirêdo; Maria Regiane A Soares; Edna A Y Ishikawa; Dorcas L Costa; Carlos H N Costa
Journal:  Am J Trop Med Hyg       Date:  2014-03-10       Impact factor: 2.345

Review 5.  Leishmaniasis, an emerging infection in travelers.

Authors:  Androula Pavli; Helena C Maltezou
Journal:  Int J Infect Dis       Date:  2010-10-16       Impact factor: 3.623

6.  FDG-PET/CT findings during immune reconstitution in an HIV-1 patient infected with visceral leishmaniasis.

Authors:  P G Kyrtatos; A Debard; G Martin-Blondel; M Alvarez; P Delobel; B Marchou; P Massip; T Wagner
Journal:  Infection       Date:  2013-05-25       Impact factor: 3.553

7.  Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy.

Authors:  A Cascio; L Gradoni; F Scarlata; M Gramiccia; S Giordano; R Russo; A Scalone; C Camma; L Titone
Journal:  Am J Trop Med Hyg       Date:  1997-07       Impact factor: 2.345

Review 8.  Leishmaniasis in travelers: a literature review.

Authors:  Pasquale Mansueto; Aurelio Seidita; Giustina Vitale; Antonio Cascio
Journal:  Travel Med Infect Dis       Date:  2014-09-28       Impact factor: 6.211

Review 9.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors:  Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

10.  Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.

Authors:  Francesco Di Masi; Tamara Ursini; Maria Donata Iannece; Leonardo Chianura; Francesco Baldasso; Giuseppe Foti; Pietro Di Gregorio; Angelo Casabianca; Nunzio Storaci; Luciano Nigro; Claudia Colomba; Maria Grazia Marazzi; Giovanni Todaro; Giacinta Tordini; Giacomo Zanelli; Giovanni Cenderello; Nicola Acone; Ennio Polilli; Simona Migliore; Paolo Almi; Eligio Pizzigallo; Evangelista Sagnelli; Francesco Mazzotta; Rosario Russo; Lamberto Manzoli; Giustino Parruti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

View more
  1 in total

1.  In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis.

Authors:  E Yaneth Osorio; Audrie A Medina-Colorado; Bruno L Travi; Peter C Melby
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.